Cardio-metabolic Prevention is Shifting from Late-Stage Management to Early, Precision Intervention

A series of recent clinical studies across hypertension, lipid management, and biomarker research signal a coordinated shift toward earlier, more precise cardiometabolic prevention, where intervention is driven by underlying biology and risk stratification rather than late-stage disease presentation.